BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saiki T. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J. 1998;45:69-73. [PMID: 9658754 DOI: 10.2739/kurumemedj.45.69] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Nascimento RDPD, Moya AMTM, Machado APDF, Geraldi MV, Diez-echave P, Vezza T, Galvez J, Cazarin CBB, Maróstica Junior MR. Review on the potential application of non-phenolic compounds from native Latin American food byproducts in inflammatory bowel diseases. Food Research International 2021;139:109796. [DOI: 10.1016/j.foodres.2020.109796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rogawski ET, Guerrant RL. The Burden of Enteropathy and "Subclinical" Infections. Pediatr Clin North Am 2017;64:815-36. [PMID: 28734512 DOI: 10.1016/j.pcl.2017.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
3 Day AS, Leach ST, Lemberg DA. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease. Expert Rev Mol Diagn. 2017;17:835-843. [PMID: 28770636 DOI: 10.1080/14737159.2017.1364160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Sangfelt P, Carlson M, Thörn M, Lööf L, Raab Y. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol. 2001;96:1085-1090. [PMID: 11316151 DOI: 10.1111/j.1572-0241.2001.03743.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
5 Garzón M, Pereira-da-Silva L, Seixas J, Papoila AL, Alves M, Ferreira F, Reis A. Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island. Pathog Glob Health 2017;111:116-27. [PMID: 28279129 DOI: 10.1080/20477724.2017.1299831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
6 McCormick BJJ, Lee GO, Seidman JC, Haque R, Mondal D, Quetz J, Lima AAM, Babji S, Kang G, Shrestha SK, Mason CJ, Qureshi S, Bhutta ZA, Olortegui MP, Yori PP, Samie A, Bessong P, Amour C, Mduma E, Patil CL, Guerrant RL, Lang DR, Gottlieb M, Caulfield LE, Kosek MN. Dynamics and Trends in Fecal Biomarkers of Gut Function in Children from 1-24 Months in the MAL-ED Study. Am J Trop Med Hyg 2017;96:465-72. [PMID: 27994110 DOI: 10.4269/ajtmh.16-0496] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
7 Iqbal NT, Sadiq K, Syed S, Akhund T, Umrani F, Ahmed S, Yakoob MY, Rahman N, Qureshi S, Xin W, Ma JZ, Hughes M, Ali SA. Promising Biomarkers of Environmental Enteric Dysfunction: A Prospective Cohort study in Pakistani Children. Sci Rep 2018;8:2966. [PMID: 29445110 DOI: 10.1038/s41598-018-21319-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
8 Becker-Dreps S, Vilchez S, Bucardo F, Twitchell E, Choi WS, Hudgens MG, Perez J, Yuan L. The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants. Pediatr Infect Dis J 2017;36:412-6. [PMID: 27977553 DOI: 10.1097/INF.0000000000001457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
9 Haque MA, Platts-Mills JA, Mduma E, Bodhidatta L, Bessong P, Shakoor S, Kang G, Kosek MN, Lima AAM, Shrestha SK, Alam MA, Havt A, Samie A, Guerrant RL, Lang D, Mahfuz M, Bhutta ZA, Houpt ER, Ahmed T. Determinants of Campylobacter infection and association with growth and enteric inflammation in children under 2 years of age in low-resource settings. Sci Rep 2019;9:17124. [PMID: 31748573 DOI: 10.1038/s41598-019-53533-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Masoodi I, Kochhar R, Dutta U, Vaishnavi C, Prasad KK, Vaiphei K, Kaur S, Singh K. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. J Gastroenterol Hepatol. 2009;24:1768-1774. [PMID: 20136960 DOI: 10.1111/j.1440-1746.2009.06048.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
11 Hino S, Ito H, Bito H, Kawagishi H, Morita T. Ameliorating effects of short-chain inulin-like fructans on the healing stage of trinitrobenzene sulfonic acid-induced colitis in rats. Biosci Biotechnol Biochem 2011;75:2169-74. [PMID: 22056441 DOI: 10.1271/bbb.110460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Taha Y, Carlson M, Thorn M, Loof L, Raab Y. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci. 2001;46:888-897. [PMID: 11330429 DOI: 10.1023/A:1010781224158] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kosek MN; MAL-ED Network Investigators. Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort Study. EBioMedicine 2017;18:109-17. [PMID: 28396264 DOI: 10.1016/j.ebiom.2017.02.024] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 23.3] [Reference Citation Analysis]
14 Yu P, Ke C, Guo J, Zhang X, Li B. Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis. Front Immunol 2020;11:575173. [PMID: 33123156 DOI: 10.3389/fimmu.2020.575173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Probert F, Walsh A, Jagielowicz M, Yeo T, Claridge TDW, Simmons A, Travis S, Anthony DC. Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative Colitis. J Crohns Colitis 2018;12:1326-37. [PMID: 30016408 DOI: 10.1093/ecco-jcc/jjy101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
16 Costa PN, Soares AM, Filho JQ, Junior FS, Ambikapathi R, Rogawski McQuade ET, Guerrant RL, Caulfield LE, Lima AAM, Maciel BLL. Dietary intake from complementary feeding is associated with intestinal barrier function and environmental enteropathy in Brazilian children from the MAL-ED cohort study. Br J Nutr 2020;123:1003-12. [PMID: 31964426 DOI: 10.1017/S0007114520000215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Uddin MI, Hossain M, Islam S, Akter A, Nishat NS, Nila TA, Rafique TA, Leung DT, Calderwood SB, Ryan ET, Harris JB, LaRocque RC, Bhuiyan TR, Qadri F. An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh. PLoS One 2021;16:e0250446. [PMID: 33886672 DOI: 10.1371/journal.pone.0250446] [Reference Citation Analysis]
18 Prata MM, Havt A, Bolick DT, Pinkerton R, Lima A, Guerrant RL. Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children. J Transl Sci 2016;2:134-9. [PMID: 27746954 DOI: 10.15761/JTS.1000130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
19 George CM, Oldja L, Biswas S, Perin J, Lee GO, Kosek M, Sack RB, Ahmed S, Haque R, Parvin T, Azmi IJ, Bhuyian SI, Talukder KA, Mohammad S, Faruque AG. Geophagy is associated with environmental enteropathy and stunting in children in rural Bangladesh. Am J Trop Med Hyg 2015;92:1117-24. [PMID: 25918214 DOI: 10.4269/ajtmh.14-0672] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 13.5] [Reference Citation Analysis]
20 Duvoisin G, Lopez RN, Day AS, Lemberg DA, Gearry RB, Leach ST. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators Inflamm 2017;2017:1936315. [PMID: 28522897 DOI: 10.1155/2017/1936315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
21 Ghafari H, Yasa N, Mohammadirad A, Dehghan G, Zamani MJ, Nikfar S, Khorasani R, Minaie B, Abdollahi M. Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity. Hum Exp Toxicol. 2006;25:325-332. [PMID: 16866190 DOI: 10.1191/0960327105ht626oa] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
22 Gough EK, Moulton LH, Mutasa K, Ntozini R, Stoltzfus RJ, Majo FD, Smith LE, Panic G, Giallourou N, Jamell M, Kosek P, Swann JR, Humphrey JH, Prendergast AJ; Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. Effects of improved water, sanitation, and hygiene and improved complementary feeding on environmental enteric dysfunction in children in rural Zimbabwe: A cluster-randomized controlled trial. PLoS Negl Trop Dis 2020;14:e0007963. [PMID: 32059011 DOI: 10.1371/journal.pntd.0007963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Khoshakhlagh P, Bahrololoumi-Shapourabadi M, Mohammadirad A, Ashtaral-Nakhai L, Minaie B, Abdollahi M. Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress. Toxicol Mech Methods. 2007;17:281-288. [PMID: 20020951 DOI: 10.1080/15376510601003769] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
24 Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate fecal biomarkers in inflammatory bowel disease: rivals or complementary tools of fecal calprotectin? Inflamm Bowel Dis. 2017;24:78-92. [PMID: 29272479 DOI: 10.1093/ibd/izx011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
25 Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, Amidou S, Mduma E, Lee G, Yori PP, Guerrant RL, Bhutta Z, Mason C, Kang G, Kabir M, Amour C, Bessong P, Turab A, Seidman J, Olortegui MP, Quetz J, Lang D, Gratz J, Miller M, Gottlieb M. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 2013;88:390-6. [PMID: 23185075 DOI: 10.4269/ajtmh.2012.12-0549] [Cited by in Crossref: 173] [Cited by in F6Publishing: 152] [Article Influence: 19.2] [Reference Citation Analysis]
26 Masoodi I, Tijjani BM, Wani H, Hassan NS, Khan AB, Hussain S. Biomarkers in the management of ulcerative colitis: a brief review. Ger Med Sci. 2011;9:Doc03. [PMID: 21394194 DOI: 10.3205/000126] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
27 Denno DM, Tarr PI, Nataro JP. Environmental Enteric Dysfunction: A Case Definition for Intervention Trials. Am J Trop Med Hyg 2017;97:1643-6. [PMID: 29016294 DOI: 10.4269/ajtmh.17-0183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
28 Abraham BP, Thirumurthi S. Clinical significance of inflammatory markers. Curr Gastroenterol Rep 2009;11:360-7. [PMID: 19765363 DOI: 10.1007/s11894-009-0055-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Ahmad G, Chami B, Liu Y, Schroder AL, San Gabriel PT, Gao A, Fong G, Wang X, Witting PK. The Synthetic Myeloperoxidase Inhibitor AZD3241 Ameliorates Dextran Sodium Sulfate Stimulated Experimental Colitis. Front Pharmacol 2020;11:556020. [PMID: 33041796 DOI: 10.3389/fphar.2020.556020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Angriman I, Scarpa M, D’Incà R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D’Amico DF, Plebani M. Enzymes in feces: useful markers of chronic inflammatory bowel disease. Clin Chim Acta. 2007;381:63-68. [PMID: 17368600 DOI: 10.1016/j.cca.2007.02.025] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
31 Masoodi I, Kochhar R, Dutta U, Vaishnavi C, Prasad KK, Vaiphei K, Hussain S, Singh K. Evaluation of fecal myeloperoxidase as a biomarker of disease activity and severity in ulcerative colitis. Dig Dis Sci 2012;57:1336-40. [PMID: 22350781 DOI: 10.1007/s10620-012-2027-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
32 Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, Mayne J, Cheng K, Liao B, Li L, Singleton R, Mack D, Stintzi A, Figeys D. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun 2018;9:2873. [PMID: 30030445 DOI: 10.1038/s41467-018-05357-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 73] [Article Influence: 31.7] [Reference Citation Analysis]
33 Vaz Nery S, Bennett I, Clarke NE, Lin A, Rahman Z, Rahman M, Clements ACA. Characterisation of environmental enteropathy biomarkers and associated risk factors in children in the context of a WASH trial in Timor-Leste. Int J Hyg Environ Health 2018;221:901-6. [PMID: 29891218 DOI: 10.1016/j.ijheh.2018.05.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 Richardson LM, Whitfield-cargile CM, Cohen ND, Chamoun-emanuelli AM, Dockery HJ. Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses. Veterinary Surgery 2018;47:784-91. [DOI: 10.1111/vsu.12941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
35 Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut. 2007;56:1706-1713. [PMID: 17675327 DOI: 10.1136/gut.2006.113431] [Cited by in Crossref: 128] [Cited by in F6Publishing: 122] [Article Influence: 9.1] [Reference Citation Analysis]
36 Poullis A, Foster R, Northfield TC, Mendall MA. Faecal markers in the assessment of activity in inflammatory bowel disease: REVIEW: FAECAL MARKERS IN IBD. Alimentary Pharmacology & Therapeutics 2002;16:675-81. [DOI: 10.1046/j.1365-2036.2002.01196.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 4.3] [Reference Citation Analysis]
37 Dai C, Jiang M, Sun M. Fecal markers in the management of inflammatory bowel disease. Postgraduate Medicine 2018;130:597-606. [DOI: 10.1080/00325481.2018.1503919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
38 Skarżyńska E, Żytyńska-daniluk J, Lisowska-myjak B. Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium. Journal of Trace Elements in Medicine and Biology 2017;43:58-62. [DOI: 10.1016/j.jtemb.2016.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Prakash O, Medhi B, Saikia UN, Pandhi P. Effect of Different Doses of Thalidomide in Experimentally Induced Inflammatory Bowel Disease in Rats. Basic Clin Pharmacol Toxicol 2008;103:9-16. [DOI: 10.1111/j.1742-7843.2008.00240.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
40 Rodriguez-Palacios A, Cominelli F. Myeloperoxidases and Proteobacteria: Reliable Interspecies Biomarkers to Identify and Monitor Pro-inflammatory Diets in Humans. Inflamm Bowel Dis 2019;25:e1-2. [PMID: 29846576 DOI: 10.1093/ibd/izy197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Sutherland AD, Gearry RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum. 2008;51:1283-1291. [PMID: 18543035 DOI: 10.1007/s10350-008-9310-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
42 Swee M, Wilson CL, Wang Y, McGuire JK, Parks WC. Matrix metalloproteinase-7 (matrilysin) controls neutrophil egress by generating chemokine gradients. J Leukoc Biol 2008;83:1404-12. [PMID: 18334539 DOI: 10.1189/jlb.0108016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
43 Tang Y, Chen Y, Wang X, Song G, Li Y, Shi L. Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis. Dig Dis Sci 2015;60:1948-57. [PMID: 25894931 DOI: 10.1007/s10620-015-3655-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
44 Arya VS, Kanthlal SK, Linda G. The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions. J Food Biochem 2020;44:e13369. [PMID: 32885438 DOI: 10.1111/jfbc.13369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
45 Chami B, San Gabriel PT, Kum-Jew S, Wang X, Dickerhof N, Dennis JM, Witting PK. The nitroxide 4-methoxy-tempo inhibits the pathogenesis of dextran sodium sulfate-stimulated experimental colitis. Redox Biol 2020;28:101333. [PMID: 31593888 DOI: 10.1016/j.redox.2019.101333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
46 Arndt MB, Richardson BA, Ahmed T, Mahfuz M, Haque R, John-Stewart GC, Denno DM, Petri WA Jr, Kosek M, Walson JL; in coordination with the MAL-ED Network Project. Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children. Am J Trop Med Hyg 2016;95:694-701. [PMID: 27352872 DOI: 10.4269/ajtmh.16-0098] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
47 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
48 Turkay C, Kasapoglu B. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo). 2010;65:221-231. [PMID: 20186307 DOI: 10.1590/S1807-59322010000200015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Hansberry DR, Shah K, Agarwal P, Agarwal N. Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease. Cureus 2017;9:e1004. [PMID: 28286723 DOI: 10.7759/cureus.1004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
50 Chami B, Martin NJ, Dennis JM, Witting PK. Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease. Archives of Biochemistry and Biophysics 2018;645:61-71. [DOI: 10.1016/j.abb.2018.03.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 22.7] [Reference Citation Analysis]
51 Rogawski ET, Guerrant RL, Havt A, Lima IFN, Medeiros PHQS, Seidman JC, McCormick BJJ, Babji S, Hariraju D, Bodhidatta L, Shrestha J, Anania J, Maro A, Samie A, Yori PP, Qureshi S, Mahfuz M, Bessong PO, Kosek MN, Ahmed T, Bhutta ZA, Lang DR, Gottlieb M, Houpt ER, Lima AAM; MAL-ED Network Investigators. Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort. PLoS Negl Trop Dis 2017;11:e0005798. [PMID: 28742106 DOI: 10.1371/journal.pntd.0005798] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
52 George CM, Oldja L, Biswas SK, Perin J, Lee GO, Ahmed S, Haque R, Sack RB, Parvin T, Azmi IJ, Bhuyian SI, Talukder KA, Faruque AG. Fecal Markers of Environmental Enteropathy are Associated with Animal Exposure and Caregiver Hygiene in Bangladesh. Am J Trop Med Hyg 2015;93:269-75. [PMID: 26055734 DOI: 10.4269/ajtmh.14-0694] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
53 Morseth MS, Henjum S, Schwinger C, Strand TA, Shrestha SK, Shrestha B, Chandyo RK, Ulak M, Torheim LE. Environmental Enteropathy, Micronutrient Adequacy, and Length Velocity in Nepalese Children: the MAL-ED Birth Cohort Study. J Pediatr Gastroenterol Nutr 2018;67:242-9. [PMID: 29620600 DOI: 10.1097/MPG.0000000000001990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]